Biblio Discovery — Demo Discovery Service

188 hasil

Menampilkan 1–20 · 0,03 detik · RSS

Jurnal

Oncology in Clinical Practice

Scopus

ISSN 2450-1654 · Via Medica · 188 artikel di indeks

  1. Artikel Jurnal

    Prognostic and predictive significance of blood cell markers in metastatic colorectal cancer treated with targeted biological agents

    Magdalena Krakowska; Sylwia Dębska-Szmich; Magdalena Grabiec dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: An increasing number of patients are living with metastatic colorectal cancer (CRC), and multipleactive drugs are available for this disease. Novel markers are needed to better select appropriate treatment.This study aimed to assess the prognostic and predictive value of complete…

  2. Artikel Jurnal

    Colonic intussusception in adults as a warning sign: revealing underlying colorectal cancer and familial adenomatous polyposis. Review of current guidelines for the management of familial adenomatous polyposis

    Julia Ciesielska; Szymon Niemiec; Andrzej Guzik dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Intussusception is a rare condition in adults and occurs far less frequently in the colon than inthe small intestine. Whereas cases involving the small intestine are typically caused by benign lesions, colonicintussusception is more commonly linked to malignant pathology, most often…

  3. Artikel Jurnal

    Efficacy of immune checkpoint inhibitors in rare oncogene-driven non-small cell lung cancer: a narrative review of BRAF, MET, HER2, RET, NTRK, and EGFR exon 20 insertions

    Paulina Kalman; Magdalena Knetki-Wróblewska

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape of advanced non-small celllung cancer (NSCLC) in patients without clinically relevant EGFR, ALK, or ROS1 alterations. However, their efficacyin rare oncogene-driven NSCLC and their optimal integration with targeted…

  4. Artikel Jurnal

    Digital soft-tissue metastasis from colorectal cancer presenting as a periungual infection during systemic therapy

    Lady Viviana Acosta-Castillo; Carolina López-Ordóñez; Laura Camila Quiroga-Cristancho dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Cutaneous and soft-tissue metastases from colorectal cancer are uncommon, and involvement of the acral regionsis particularly rare. We report the case of a 28-year-old man with metastatic rectal adenocarcinoma (cT4N1M1)who developed a rapidly progressive lesion involving the left fifth finger…

  5. Artikel Jurnal

    Squamous cell lung cancer in a 25-year-old man after short-term asbestos exposure

    Tobiasz Wróblewski; Katarzyna Ostrowska; Paulina Wesołowska dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    A 25-year-old male patient was admitted to the Department of Pneumonology, Oncology and Allergologybecause of non-small cell carcinoma of the left lung with squamous cell and NOS components. His medicalhistory included an episode of removing asbestos from a roof without protective equipment for…

  6. Artikel Jurnal

    Early-onset colorectal cancer: a distinct entity or a continuum of the same disease? A narrative review

    Maria Rozpłoch-Sapa; Paweł M. Potocki; Piotr J. Wysocki

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Colorectal cancer (CRC) is one of the most common cancers and a leading contributor to cancer-related mortality, both globally and in Poland. Early-onset colorectal cancer (EOCRC) currently accounts for approximately 10% of all CRC cases. Epidemiological data indicate that EOCRC incidence is…

  7. Artikel Jurnal

    Fatal pulmonary hypertension during long-term alectinib therapy in ALK-positive non-small cell lung cancer: adverse drug reaction or disease-related complication?

    Jan Chmielewski; Elżbieta Czekajska-Chehab; Edyta Opalińska dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    ALK gene rearrangements occur in approximately 4% of patients with non-small cell lung cancer (NSCLC).Treatment with ALK inhibitors is highly effective and generally well tolerated. Pulmonary arterial hypertension(PAH) has rarely been described in association with ALK inhibitor therapy, and…

  8. Artikel Jurnal

    Bilateral primary lung adenocarcinomas with distinct EGFR mutations in a patient with Li-Fraumeni syndrome

    Alicja M. Jarząbek; Damian Tworek

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Li-Fraumeni syndrome (LFS) is a rare hereditary cancer predisposition syndrome associatedwith germline TP53 variants and a markedly increased risk of early-onset and multiple primary malignancies.Although lung cancer is not considered a core LFS-associated tumor, increasing evidence…

  9. Artikel Jurnal

    Malignant melanoma with cardiac involvement: a case report and literature review

    Aleksander Gorzeń; Tomasz Świtaj; Paweł Rogala dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Malignant melanoma is the tumor most frequently associated with cardiac metastases. Melanocytes originate from the neural crest, which may underlie the tumor’s propensity for widespread hematogenous dissemi-nation, including to the heart. Cardiac involvement is found in up to 64% of…

  10. Artikel Jurnal

    Miejsce atezolizumabu w leczeniu chorych na niedrobnokomórkowego raka płuca w starszym wieku – nowe możliwości i wyzwania

    Magdalena Knetki-Wróblewska; Katarzyna Broczek; Damian Tworek dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Rak płuca pozostaje wiodącą przyczyną zgonów z powodu chorób nowotworowych, a większość zachorowań na niedrobnokomórkowego raka płuca (NDRP) dotyczy osób w starszym wieku. Chorzy ci — ze względu na choroby współistniejące, obniżoną rezerwę biologiczną oraz zespół kruchości — często nie kwalifikują…

  11. Artikel Jurnal

    Correlation between psoas muscle volume measured during neoadjuvant radio-chemotherapy treatment for locally advanced rectal cancer and tumor response: a single-centre experience

    Nadine M. G. Grillone; Carmelo Tuscano; Anna M. Marchione dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: This study investigates the prognostic impact of intra-treatment psoas muscle loss, assessed by cone-beam CT (CBCT), on tumour regression and gastrointestinal toxicity in locally advanced rectal cancer (LARC) patients receiving neoadjuvant radiochemotherapy. MATERIAL AND METHODS…

  12. Artikel Jurnal

    What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?

    Sylwia Dębska-Szmich; Piotr Potemski

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Pathogenic or likely pathogenic germline BRCA1/2 variants (gBRCA1/2m) occur in about 5% of unselected breast cancer patients, but their incidence is higher in patients with a family history of breast cancer, a diagnosis before the age of 50, synchronous or metachronous second breast cancer or…

  13. Artikel Jurnal

    Stanowisko ekspertów w zakresie diagnostyki szlaku sygnałowego PI3K–AKT–mTOR w hormonozależnym raku piersi

    Barbara Radecka; Małgorzata Stawicka-Niełacna; Małgorzata Oczko-Wojciechowska dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Szlak PI3K–AKT–mTOR reguluje wzrost, przeżycie i metabolizm komórek. Jego nadmierna aktywacja jest jednym z kluczowych mechanizmów rozwoju i progresji raka piersi, zwłaszcza podtypu HR+/HER2–, oraz istotnym czynnikiem powstawania hormonooporności podczas leczenia hormonalnego. Najważniejsze…

  14. Artikel Jurnal

    First real-world experience with first-line pembrolizumab and chemotherapy treatment for advanced triple-negative breast cancer in Poland: safety analysis and first survival outcomes from a multicenter cohort

    Małgorzata Pieniążek; Aleksandra Konieczna; Katarzyna Świderska dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Pembrolizumab combined with chemotherapy has improved clinical outcomes in programmed death-ligand 1 (PD-L1) positive metastatic triple-negative breast cancer (mTNBC) in the KEYNOTE-355 trial. However, real-world studies confirming these data are lacking. We aimed to evaluate the…

  15. Artikel Jurnal

    Complications of neuro-oncological treatment: neurological, endocrine, and systemic adverse effects

    Elzbieta Dziedzic; Jolanta Zapędowska; Krzysztof Zawiślak dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Progress in neuro-oncology has improved survival in patients with primary and secondary cen­tral nervous system tumors. As a result, treatment-related complications have become increasingly important in everyday practice, particularly in long-term survivors. These adverse effects…

  16. Artikel Jurnal

    Utility of circulating tumor DNA in detecting actionable mutations in metastatic non-small-cell lung cancer

    Gabriela Isabel Gálvez; Miguel Ángel Fernández

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    Lung cancer, identified as the leading cause of cancer death according to the WHO, remains a global challenge for diagnosis and treatment. Lung cancer is classified into two main categories: small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). NSCLC is the most common type…

  17. Artikel Jurnal

    Radiotherapy of head and neck cancer using volumetric modulated arc therapy (VMAT): a dosimetric and clinical comparison of moderately hypofractionated versus standard fractionation

    Gleetus Thimothy; Anuj Vijay; Mary Joan

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Radiotherapy (RT) is an important treatment strategy for head and neck cancers (HNC) although it remains challenging due to the anatomical complexity and intensity of nontoxic regimen. Standard fractionation radiation therapy (SFRT) is the standard approach to delivering RT however…

  18. Artikel Jurnal

    The sea that holds me: psychological outcomes of a sailing-based intervention in women with a history of cancer

    Julia Wyszomirska; Patrycja Romaniszyn-Kania; Monika Bąk-Sosnowska

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    INTRODUCTION: Sailing-based interventions combine physical activity, exposure to nature, and social bonding, which may support psychological well-being in people with cancer. However, controlled evidence for such com­plex experiential interventions remains limited. The present study aimed to…

  19. Artikel Jurnal

    The role of NTRK gene fusions in the biology and treatment of solid tumors

    Wojciech Kopyciński; Adrianna Baran; Maria Czerniawska dkk.

    Oncology in Clinical Practice, Vol. 22 No. Continuous Publishing · 2026 · Inggris · DOAJ Scopus

    NTRK gene fusions are rare but crucial oncogenic drivers across various solid tumors. They are more frequent in rare cancers, such as secretory carcinomas and found less commonly in common malignancies such as colorectal cancer, NSCLC, thyroid carcinoma, pancreatic carcinoma, and…